NASDAQ traded attribute type Security_Name was changed. Previous value: Mind Medicine (MindMed) Inc. - Common Shares. New value: Denium Therapeutics, Inc - Common Shares.
NASDAQ traded attribute type Security_Name was changed. Previous value: iRhythm Technologies, Inc. - Common Stock. New value: iRhythm Holdings, Inc. - Common Stock.
Director Laumas Sandeep 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002981
Director Patni Rajiv 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002980
Galbraith Kenneth 🟡 adjusted position in 551.6K shares (4 derivative) of Zymeworks Inc. (ZYME) at $23.16 ($5.7M) Transaction Date: Jan 12, 2026 | Filing ID: 010790
Director MUELLER PETER 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002979
Director Votruba Michal 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002978
Director MILLER MICHAEL PATRICK 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002976
Director Bray June 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002975
Director MACK DAVID J. 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002973